Revance Therapeutics Inc (RVNC)
3.31
-0.98
(-22.84%)
USD |
NASDAQ |
May 10, 16:00
3.31
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Market Cap: 344.95M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 447.08M |
| May 08, 2024 | 444.99M |
| May 07, 2024 | 456.46M |
| May 06, 2024 | 427.28M |
| May 03, 2024 | 411.65M |
| May 02, 2024 | 392.89M |
| May 01, 2024 | 395.49M |
| April 30, 2024 | 376.21M |
| April 29, 2024 | 384.55M |
| April 26, 2024 | 354.33M |
| April 25, 2024 | 342.86M |
| April 24, 2024 | 372.04M |
| April 23, 2024 | 381.42M |
| April 22, 2024 | 379.34M |
| April 19, 2024 | 393.93M |
| April 18, 2024 | 394.97M |
| April 17, 2024 | 391.84M |
| April 16, 2024 | 397.06M |
| April 15, 2024 | 413.73M |
| April 12, 2024 | 430.40M |
| April 11, 2024 | 462.71M |
| April 10, 2024 | 459.58M |
| April 09, 2024 | 488.76M |
| April 08, 2024 | 463.75M |
| April 05, 2024 | 459.58M |
| Date | Value |
|---|---|
| April 04, 2024 | 459.58M |
| April 03, 2024 | 474.17M |
| April 02, 2024 | 470.01M |
| April 01, 2024 | 492.93M |
| March 28, 2024 | 512.73M |
| March 27, 2024 | 514.82M |
| March 26, 2024 | 489.81M |
| March 25, 2024 | 484.60M |
| March 22, 2024 | 507.52M |
| March 21, 2024 | 540.87M |
| March 20, 2024 | 528.37M |
| March 19, 2024 | 513.78M |
| March 18, 2024 | 514.82M |
| March 15, 2024 | 552.86M |
| March 14, 2024 | 565.88M |
| March 13, 2024 | 627.37M |
| March 12, 2024 | 654.99M |
| March 11, 2024 | 652.38M |
| March 08, 2024 | 626.33M |
| March 07, 2024 | 641.96M |
| March 06, 2024 | 660.72M |
| March 05, 2024 | 573.39M |
| March 04, 2024 | 535.46M |
| March 01, 2024 | 615.73M |
| February 29, 2024 | 629.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
342.86M
Minimum
Apr 25 2024
3.161B
Maximum
May 09 2023
1.421B
Average
1.398B
Median
Mar 23 2022
Market Cap Benchmarks
| AbbVie Inc | 283.86B |
| Eli Lilly and Co | 722.44B |
| Aquestive Therapeutics Inc | 226.87M |
| Humacyte Inc | 558.51M |
| AN2 Therapeutics Inc | 72.78M |
Market Cap Related Metrics
| PS Ratio | 1.196 |
| Price | 3.31 |
| Earnings Yield | -114.8% |